AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24481580
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg dexketoprofen (GD)
Trial: 11898004
Drug: 0.1% tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% tacrolimus ointment
Trial: 20169301
Drug: Corticosteroid regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid regimen (hydrocortisone acetate 1% ointment for head and neck, hydrocortisone butyrate 0.1% ointment for trunk and limbs)
Trial: 17570057
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of Divalproex sodium (DVP)
Trial: 17570057
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of Divalproex sodium (DVP)
Trial: 16251796
Drug: Prenatal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal and postnatal fluoride supplements
Trial: 16983056
Drug: Sildenafil 50
RxNorm normalized name: sildenafil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 50 mg
Trial: 11045181
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fluvastatin (20 mg daily) and fenofibrate (200 mg daily)
Trial: 8736279
Drug: Full replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full replacement therapy (thyroxine)
Trial: 8736279
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion at 25 ng/kg/min for 30 minutes
Trial: 7577887
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion
Trial: 1895900
Drug: OTM-01A ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OTM-01A ophthalmic tonometer
Trial: 6624778
Drug: Aerosol albuterol
RxNorm normalized name: Albuterol Inhalation Aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol albuterol (3 puffs)
Trial: 6624778
Drug: Oral aminophylline
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aminophylline (400 mg) and terbutaline sulfate (5 mg)
Trial: 27610741
Drug: Modular evidence-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modular evidence-based treatment targeting comorbid mental health problems
Trial: 27610741
Drug: Modular evidence-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modular evidence-based treatment focusing on principal clinical problems
Trial: 18990168
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (control)
Trial: 9327366
Drug: Spray-dried bovine
RxNorm normalized name: thrombin, bovine Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray-dried bovine serum concentrate (25% replacement of milk protein)
Trial: 9327366
Drug: Spray-dried bovine
RxNorm normalized name: thrombin, bovine Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray-dried bovine serum concentrate (50% replacement of milk protein)
Trial: 9327366
Drug: Spray-dried bovine
RxNorm normalized name: thrombin, bovine Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray-dried bovine serum concentrate (25% and 50% replacement)
Trial: 8227760
Drug: Disulfiram (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disulfiram (800 mg) during dexamethasone and postdexamethasone days
Trial: 31339403
Drug: Group‐task‐oriented training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group‐task‐oriented training (group‐TOT) for 1 hour, twice a week for 8 weeks
Trial: 31339403
Drug: Individualized traditional
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized traditional physical and occupational therapy (comparison group)
Trial: 27544584
Drug: qHPV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: qHPV vaccine (0.5mL) administered intramuscularly at months 0, 2, and 6
Trial: 22736125
Drug: 1 day
RxNorm normalized name: ZonaCort 11 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 day of bowel preparation
Trial: 22736125
Drug: 3 days
RxNorm normalized name: Transderm Scop 1mg/3 days Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 days of bowel preparation
Trial: 18676533
Drug: Cod liver
RxNorm normalized name: Cod Liver Oil
DrugBank: Cod liver oil (DB11321)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cod liver oil (10 mL daily from week 18 of pregnancy until 3 months after delivery)
Trial: 18676533
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (10 mL daily from week 18 of pregnancy until 3 months after delivery)
Trial: 24874315
Drug: EGb 761
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGb 761 (240 mg per day for 24 weeks)
Trial: 24874315
Drug: Other drugs
RxNorm normalized name: Other drugs for bile therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other drugs (control group)
Trial: 28105515
Drug: Azosemide (long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azosemide (long-acting loop diuretic)
Trial: 17587724
Drug: Furosemide (short-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (short-acting loop diuretic)
Trial: 18300446
Drug: 24-hour pH
RxNorm normalized name: PH-284
DrugBank: PH-284 (DB05452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour pH monitoring with antacid treatment (omeprazole)
Trial: 18300446
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with antacid treatment (omeprazole) only
Trial: 2533866
Drug: 10 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms of B‐Hepavac II vaccine
Trial: 2533866
Drug: 5 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 micrograms of B‐Hepavac II vaccine
Trial: 779705
Drug: Methadyl acetate
RxNorm normalized name: Methadyl acetate
DrugBank: Methadyl acetate (DB01433)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadyl acetate (80 mg three times a week)
Trial: 779705
Drug: High-dose methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methadone (50 mg daily or 100 mg daily)
Trial: 21076361
Drug: Low-dose methadone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methadone
Trial: 28472530
Drug: Nutrition intervention
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition intervention for 3 months with individualized nutrition care plan plus monthly post-discharge telehealth follow-up
Trial: 23147558
Drug: SRP+SDD (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP+SDD (20 mg of doxycycline twice daily)
Trial: 17519642
Drug: Olanzapine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (2.5 mg for 1 month, 5 mg for 2 months)
Trial: 17519642
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy + Olanzapine
Trial: 11423814
Drug: Intravenous pyridoxine
RxNorm normalized name: PYRIDOXINE
DrugBank: Pyridoxine phosphate (DB02209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous pyridoxine (5 g over 5 minutes)
Trial: 11423814
Drug: Intravenous placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous placebo (50 mL of normal saline solution)
Trial: 8094168
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg aspirin daily until delivery
Trial: 31940793
Drug: Convolutional neural
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Convolutional neural network for PPI site prediction; improved data set; specific details on dosage and duration not applicable.
Trial: 9249121
Drug: Morphine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.1 mg/kg)
Trial: 26938140
Drug: Acetaminophen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1 g)
Trial: 26938140
Drug: Morphine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.1 mg/kg) and Acetaminophen (1 g)
Trial: 23263176
Drug: Early antiretroviral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early antiretroviral therapy (ART) initiated at enrollment (n = 139)
Trial: 23263176
Drug: Deferred antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred antiretroviral therapy (ART) initiated when CD4 count <15% or CDC category C event developed (n = 145)
Trial: 21463065
Drug: Oxycodone 20
RxNorm normalized name: oxycodone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 20 mg
Trial: 21395483
Drug: Oxycodone/Naloxone 20/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone/Naloxone 20/10 mg
Trial: 31764725
Drug: Oxycodone 10
RxNorm normalized name: oxycodone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 10 mg
Trial: 10634373
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (600 mg/day)
Trial: 18339123
Drug: Melatonin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (3 mg/day) and Vitamin E (600 mg/day)
Trial: 18339123
Drug: No melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No melatonin treatment
Trial: 16797388
Drug: GLA 2.2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLA 2.2% cream
Trial: 16797388
Drug: Placebo-based cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo-based cream
Trial: 12506030
Drug: Donor pretransplantation
RxNorm normalized name: Donor Human Stool
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donor pretransplantation antibody levels
Trial: 12506030
Drug: Patient or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient or donor age, total body irradiation, and graft‐versus‐host disease or its treatment
Trial: 10730983
Drug: Continuous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous oxytocin infusion (1:9 mg/d) on Days 14 to 26 after estrus
Trial: 10730983
Drug: Oxytocin injections
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin injections (0.33 USP units/kg body weight, s.c.) twice daily on Days 3 to 6 of the estrous cycle
Trial: 1466940
Drug: Ketotifen (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen (0.5 mg) syrup, 2.5 mL twice daily
Trial: 1466940
Drug: Placebo syrup,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo syrup, 2.5 mL twice daily
Trial: 31907033
Drug: Negative-pressure wound
RxNorm normalized name: Microcyn Negative-Pressure Wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative-pressure wound therapy (NPWT) using the PICO™ system
Trial: 26123563
Drug: Tenofovir gel
RxNorm normalized name: Tenofovir
DrugBank: Tenofovir (DB14126)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tenofovir gel
Trial: 15356495
Drug: Extended prophylaxis
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended prophylaxis regimen including regular mechanical tooth cleaning by a hygienist, scaling, and chlorhexidine treatment.
Trial: 15356495
Drug: Initial prophylaxis
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial prophylaxis alone consisting of patient motivation, oral hygiene checkups, and fluoridation.
Trial: 12073159
Drug: THC-only (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC-only (low dose)
Trial: 12073159
Drug: THC-only (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC-only (high dose)
Trial: 12073159
Drug: Whole-plant marijuana
RxNorm normalized name: century plant whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-plant marijuana (low dose)
Trial: 12073159
Drug: Whole-plant marijuana
RxNorm normalized name: century plant whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-plant marijuana (high dose)
Trial: 10445600
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group A: Low dose inhaled corticosteroids (< or =400 microg/day)
Trial: 10445600
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group B: Oral corticosteroids (> or =10 mg/day)
Trial: 7769071
Drug: Intracytoplasmic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic injection with live spermatozoa
Trial: 7769071
Drug: Intracytoplasmic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic injection with dead spermatozoa
Trial: 7769071
Drug: Intracytoplasmic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic injection without a spermatozoon
Trial: 7769071
Drug: Intracytoplasmic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic injection of human sperm cytosolic fraction (CF)
Trial: 7769071
Drug: Intracytoplasmic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic injection of human sperm cytosolic fraction (CF) in mouse oocytes
Trial: 7769071
Drug: Intracytoplasmic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic injection of CF after heat treatment
Trial: 2179521
Drug: Haloperidol treatment
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol treatment for 26 days
Trial: 6849726
Drug: Methotrimeprazine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrimeprazine 7.5 mg i.m.
Trial: 9283163
Drug: Morphine 5
RxNorm normalized name: ethylmorphine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 5 mg
Trial: 6849726
Drug: Methotrimeprazine (small
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrimeprazine (small non-sedative doses)
Trial: 25046950
Drug: Shen‐reinforcing and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shen‐reinforcing and menstrual cycle‐regulating therapy combined with Western medicine (IM group)
Trial: 25046950
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (WM group)
Trial: 22296973
Drug: Oestradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oestradiol valerate (2 · 2 mg daily for 6–10 days)
Trial: 14715345
Drug: Full-dose reteplase
RxNorm normalized name: reteplase
DrugBank: Reteplase (DB00015)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full-dose reteplase
Trial: 14715345
Drug: Half-dose reteplase
RxNorm normalized name: reteplase
DrugBank: Reteplase (DB00015)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Half-dose reteplase with full-dose abciximab
Trial: 9297428
Drug: rH‐EPO (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rH‐EPO (200 U/kg body weight subcutaneously once a day, three days a week for 4 weeks) with oral ferrous sulfate (4 mg/kg/day)
Trial: 7952423
Drug: Early medical
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early medical therapy
Trial: 3674795
Drug: Oral physostigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral physostigmine (mode = 13 mg/day)
Trial: 2189429
Drug: Oral physostigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral physostigmine
Trial: 31942840
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (100 mg) in addition to standard treatment
Trial: 12577242
Drug: Amifostine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (200 mg/m2/d before radiation)
Trial: 12577242
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (radiation therapy 64.8 Gy, paclitaxel, carboplatin, followed by cisplatin and gemcitabine)
Trial: 15335530
Drug: 0.05% aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% aqueous alcohol solution (1 ml)
Trial: 15335530
Drug: 0.10% aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.10% aqueous alcohol solution (1 ml)
Trial: 15335530
Drug: 0.15% aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15% aqueous alcohol solution (1 ml)
Trial: 7975842
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine expressed in mutant yeast (non-hyperglycosylated preS2 + 2 polypeptide)
Trial: 7975842
Drug: Licensed HB
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Licensed HB vaccine
Trial: 7975842
Drug: Hyperglycosylated preS2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperglycosylated preS2 + 2 vaccine
Trial: 28761069
Drug: Biomarker-positive patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biomarker-positive patients receiving FDA-approved oncology drugs with required pharmacogenomic biomarker testing
Trial: 15389187
Drug: Infliximab 3
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab 3 mg/kg
Trial: 15389187
Drug: Infliximab 5
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab 5 mg/kg
Trial: 19203570
Drug: diclofenac-cholestyramine 140
RxNorm normalized name: cholestyramine resin / diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac-cholestyramine 140 mg capsule formulation
Trial: 17363401
Drug: 110 mg
RxNorm normalized name: lactase 110 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 110 mg epicutaneous ketoprofen in 4.8 g Transfersome
Trial: 17363401
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg oral celecoxib
Trial: 15371062
Drug: Client-centered therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Client-centered therapy for childhood traumatic grief (CTG)
Trial: 11430439
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity laser therapy (830nm) at a dosage of 9 J/cm2
Trial: 2297460
Drug: Oxazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam (15 mg) + Propranolol (80 mg)
Trial: 2297460
Drug: Oxazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam (15 mg) + Labetalol (200 mg)
Trial: 2297460
Drug: Oxazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam (15 mg) + Propranolol (80 mg) + Labetalol (200 mg)
Trial: 2793265
Drug: Labetalol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (200 mg)
Trial: 28659293
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg Fe · kg‐1 · d‐1
Trial: 28659293
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg Fe · kg‐1 · d‐1
Trial: 28659293
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (combined 1 or 2 mg Fe · kg‐1 · d‐1)
Trial: 25952050
Drug: Experimental handwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental handwash formulations (sand)
Trial: 6361287
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose methylprednisolone
Trial: 9489539
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with preceding gastrointestinal illness, initial predominant distal weakness, acute motor neuropathy, or anti-GM1 antibodies
Trial: 9489539
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with treatment related fluctuations
Trial: 1537493
Drug: Liquid meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid meal in combination with propranolol
Trial: 6373157
Drug: oxpentifylline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxpentifylline (200 mg 3-times daily)
Trial: 31148494
Drug: Radial Shockwave
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radial Shockwave Therapy (rSWT) + Standard Orthotic Management (SOM)
Trial: 29557855
Drug: Long-term medication-assisted
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term medication-assisted treatment (LT-MAT) with buprenorphine/naloxone
Trial: 29557855
Drug: Short-term medication-assisted
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term medication-assisted treatment (C)
Trial: 20961967
Drug: Pioglitazone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (15 mg/day, n=34)